These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17333299)

  • 41. Molecular dynamics study of the Cu2+ binding-induced "structuring" of the N-terminal domain of human prion protein.
    Valensin G; Molteni E; Valensin D; Taraszkiewicz M; Kozlowski H
    J Phys Chem B; 2009 Mar; 113(11):3277-9. PubMed ID: 19236027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural, EPR superhyperfine, and NMR hyperfine properties of the Cu-octarepeat binding site in the prion protein.
    Ling Y; Khade RL; Zhang Y
    J Phys Chem B; 2011 Mar; 115(11):2663-70. PubMed ID: 21355614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches.
    Todorova-Balvay D; Simon S; Créminon C; Grassi J; Srikrishnan T; Vijayalakshmi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):75-82. PubMed ID: 15722047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A re-investigation of copper coordination in the octa-repeats region of the prion protein.
    Bonomo RP; Cucinotta V; Giuffrida A; Impellizzeri G; Magri A; Pappalardo G; Rizzarelli E; Santoro AM; Tabbi G; Vagliasindi LI
    Dalton Trans; 2005 Jan; (1):150-8. PubMed ID: 15605159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry.
    Davies P; Marken F; Salter S; Brown DR
    Biochemistry; 2009 Mar; 48(12):2610-9. PubMed ID: 19196019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dimeric and tetrameric octarepeat fragments of prion protein behave differently to its monomeric unit.
    Valensin D; Luczkowski M; Mancini FM; Legowska A; Gaggelli E; Valensin G; Rolka K; Kozlowski H
    Dalton Trans; 2004 May; (9):1284-93. PubMed ID: 15252619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies.
    Gaggelli E; Bernardi F; Molteni E; Pogni R; Valensin D; Valensin G; Remelli M; Luczkowski M; Kozlowski H
    J Am Chem Soc; 2005 Jan; 127(3):996-1006. PubMed ID: 15656638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions.
    Thakur AK; Srivastava AK; Srinivas V; Chary KVR; Rao CM
    J Biol Chem; 2011 Nov; 286(44):38533-38545. PubMed ID: 21900252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prion protein selectively binds copper(II) ions.
    Stöckel J; Safar J; Wallace AC; Cohen FE; Prusiner SB
    Biochemistry; 1998 May; 37(20):7185-93. PubMed ID: 9585530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insertion of beta-alanine in model peptides for copper binding to His96 and His111 of the human prion protein.
    Rivillas-Acevedo L; Maciel-Barón L; García JE; Juaristi E; Quintanar L
    J Inorg Biochem; 2013 Sep; 126():104-10. PubMed ID: 23796442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One octarepeate expansion to the human prion protein alters both the Zn2+ and Cu2+ coordination environments within the octarepeate domain.
    Shearer J; Rosenkoetter KE; Callan PE; Pham C
    Inorg Chem; 2011 Feb; 50(4):1173-5. PubMed ID: 21250682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prion protein binds copper within the physiological concentration range.
    Kramer ML; Kratzin HD; Schmidt B; Römer A; Windl O; Liemann S; Hornemann S; Kretzschmar H
    J Biol Chem; 2001 May; 276(20):16711-9. PubMed ID: 11278306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Copper-induced structural propensities of the amyloidogenic region of human prion protein.
    Migliorini C; Sinicropi A; Kozlowski H; Luczkowski M; Valensin D
    J Biol Inorg Chem; 2014 Jun; 19(4-5):635-45. PubMed ID: 24737041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Copper binding extrinsic to the octarepeat region in the prion protein.
    Walter ED; Stevens DJ; Spevacek AR; Visconte MP; Dei Rossi A; Millhauser GL
    Curr Protein Pept Sci; 2009 Oct; 10(5):529-35. PubMed ID: 19538144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Copper(II)-induced secondary structure changes and reduced folding stability of the prion protein.
    Younan ND; Klewpatinond M; Davies P; Ruban AV; Brown DR; Viles JH
    J Mol Biol; 2011 Jul; 410(3):369-82. PubMed ID: 21619885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
    Redecke L; Meyer-Klaucke W; Koker M; Clos J; Georgieva D; Genov N; Echner H; Kalbacher H; Perbandt M; Bredehorst R; Voelter W; Betzel C
    J Biol Chem; 2005 Apr; 280(14):13987-92. PubMed ID: 15684434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prion Protein Octarepeat Domain Forms Transient β-Sheet Structures upon Residue-Specific Binding to Cu(II) and Zn(II) Ions.
    Gielnik M; Szymańska A; Dong X; Jarvet J; Svedružić ŽM; Gräslund A; Kozak M; Wärmländer SKTS
    Biochemistry; 2023 Jun; 62(11):1689-1705. PubMed ID: 37163663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the copper(II) ion coordination by prion protein HGGGW pentapeptide model.
    Marino T; Russo N; Toscano M
    J Phys Chem B; 2007 Jan; 111(3):635-40. PubMed ID: 17228921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4.
    Wells MA; Jelinska C; Hosszu LL; Craven CJ; Clarke AR; Collinge J; Waltho JP; Jackson GS
    Biochem J; 2006 Dec; 400(3):501-10. PubMed ID: 16925523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.